SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Telemetry Investments, L.L.C.

CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700

Reported Value
$35M
Q3 2019
Positions
53
Filings on Record
17
2019–present window
Filed
Nov 14, 2019
original filing

Summary

Telemetry Investments, L.L.C. reported $35M in U.S.-listed holdings across 53 positions for Q3 2019.

Its largest position, CELG, represents 6.9% of the portfolio.

Compared with Q2 2019, the fund opened 11 new positions and exited 38.

Portfolio Metrics

Turnover
+8.1%
vs prior filed quarter
Top-10 Concentration
+53.2%
share of reported value
Largest Position
+6.9%
Celgene
New / Exited
11 / 38
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $157MQ4 ’18Q1 ’19: $197MQ2 ’19: $129MQ2 ’19Q3 ’19: $35MQ4 ’19: $30MQ4 ’19Q1 ’20: $29MQ2 ’20: $37MQ2 ’20Q3 ’20: $46MQ4 ’20: $59MQ4 ’20Q1 ’21: $88MQ2 ’21: $73MQ2 ’21Q3 ’21: $74MQ4 ’21: $78MQ4 ’21Q1 ’22: $63MQ2 ’22: $84MQ2 ’22Q3 ’22: $78Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.4%Other: 15.6%US DOMESTIC: 7.1%ETP: 1.8%MLP: 1.7%REIT: 0.5%
  • Common Stock · 73.4% · $25M
  • Other · 15.6% · $5M
  • US DOMESTIC · 7.1% · $2M
  • ETP · 1.8% · $625,000
  • MLP · 1.7% · $577,000
  • REIT · 0.5% · $172,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ALLERGAN PLCNEW+11.7K11.7K+$2M$2M
ACIAACACIA COMMUNICATIONS INCNEW+6.0K6.0K+$392,000$392,000
CARBON BLACK INCNEW+13.0K13.0K+$338,000$338,000
BIDSOTHEBYSNEW+3.9K3.9K+$224,000$224,000
GENESEE & WYO INCNEW+2.0K2.0K+$221,000$221,000
BROOKFIELD ASSET MGMT INCNEW+4.2K4.2K+$221,000$221,000
GANNETT CO INCNEW+17.6K17.6K+$189,000$189,000
CONDOR HOSPITALITY TR INCNEW+15.6K15.6K+$172,000$172,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

49 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CELGCELGENE CORPhistory →COM6.87%$2M24.0K
2KDMNKADMON HLDGS INChistory →COM6.48%$2M891.5K
3EIGER BIOPHARMACEUTICALS INCCOM6.42%$2M217.0K
4XTNTXTANT MED HLDGS INChistory →COM NEW6.32%$2M771.5K
5WELLCARE HEALTH PLANS INCCOM6.05%$2M8.1K
6ALLERGAN PLCSHS5.68%$2M11.7K
7VERSUM MATLS INCCOM5.57%$2M36.5K
8VERASTEM INCNOTE 5.000%11/0 · COM3.38%$1M2.44M
9ZOSANO PHARMA CORPCOM NEW3.27%$1M726.4K
10PARATEK PHARMACEUTICALS INCNOTE 4.750% 5/03.13%$1M1.50M
11MEDIDATA SOLUTIONS INCCOM2.59%$897,0009.8K
12DERMIRA INCCOM2.54%$882,000138.0K
13AFFIMED N VCOM2.38%$825,000280.7K
14MELLANOX TECHNOLOGIES LTDSHS1.99%$689,0006.3K
15GLOBALSTAR INCCOM1.89%$657,0001.59M
16GLDSPDR GOLD TRUSThistory →GOLD SHS1.80%$625,0004.5K
17BUCKEYE PARTNERS L PUNIT LTD PARTN1.66%$577,00014.0K
18SPRINT CORPORATIONCOM1.32%$457,00074.0K
19VRAYQVIEWRAY INChistory →COM1.27%$440,000151.6K
20RIGEL PHARMACEUTICALS INCCOM NEW1.23%$425,000227.5K
21STEMLINE THERAPEUTICS INCCOM1.20%$416,00040.0K
22EL PASO ELEC COCOM NEW1.16%$402,0006.0K
23ACIAACACIA COMMUNICATIONS INChistory →COM1.13%$392,0006.0K
24CICIGNA CORP NEWhistory →COM1.01%$350,0002.3K
25NOVAVAX INCNOTE 3.750% 2/00.99%$344,000825.0K
26CARBON BLACK INCCOM0.97%$338,00013.0K
27NEMNEWMONT GOLDCORP CORPORATIONCOM0.94%$325,0008.6K
28ENDOLOGIX INCCOM NEW0.93%$323,00081.5K
29TRACON PHARMACEUTICALS INCCOM0.93%$321,000717.8K
30WFCWELLS FARGO CO NEWCOM0.90%$312,0006.2K
31SIERRA ONCOLOGY INCCOM0.89%$307,000786.8K
32ADMAADMA BIOLOGICS INCCOM0.82%$285,00064.0K
33ABXBARRICK GOLD CORPORATIONCOM0.80%$277,00016.0K
34MATINAS BIOPHARMA HLDGS INCCOM0.78%$272,000431.5K
35GSGOLDMAN SACHS GROUP INCCOM0.72%$249,0001.2K
36ADPAUTOMATIC DATA PROCESSING INCOM0.70%$242,0001.5K
37ACRSACLARIS THERAPEUTICS INCCOM0.67%$232,000214.6K
38BIDSOTHEBYSCOM0.65%$224,0003.9K
39BROOKFIELD ASSET MGMT INCCL A LTD VT SH0.64%$221,0004.2K
40GENESEE & WYO INCCL A0.64%$221,0002.0K
41MSFTMICROSOFT CORPCOM0.60%$209,0001.5K
42WABCO HLDGS INCCOM0.58%$201,0001.5K
43GANNETT CO INCCOM0.55%$189,00017.6K
44CONDOR HOSPITALITY TR INCCOM NEW0.50%$172,00015.6K
45BELLEROPHON THERAPEUTICS INCCOM0.47%$163,000338.0K
46ROSEHILL RES INCCL A · *W EXP 04/27/2020.39%$135,000124.4K
47SNDXSYNDAX PHARMACEUTICALS INCCOM0.28%$97,00013.0K
48ORMPORAMED PHARM INCCOM NEW0.09%$32,00010.0K
49AROTECH CORPCOM NEW0.08%$29,00010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2022Under review146Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$78M177Nov 17, 202213F-HRchanges · EDGAR ↗
Q2 2022$84M177Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$63M165May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$78M178Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$74M160Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$73M139Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$88M126May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$59M89Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$46M73Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$37M65Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$29M54May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$30M41Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$35M53Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$129M82Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$197M101May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$157M136Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.